Am. J. Respir. Cell Mol. Biol., Vol 14, No. 1, Jan 1996, 53-60.
The role of fibrin degradation products in neutrophil recruitment to the lung
KJ Leavell, MW Peterson and TJ Gross
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City, USA.
Pulmonary epithelial injury leads to increased permeability and plasma
exudation. Plasma rapidly forms an insoluble fibrin clot in the distal
airspace because of the potent procoagulant activity expressed there.
Because these airspaces also express potent fibrinolytic activity,
digestion of fibrin results in high local concentrations of fibrin
degradation products (FDP), which are biologically important molecules with
numerous proinflammatory actions. Inflammatory lung injury is associated
with neutrophil accumulation, and other matrix proteins affect inflammatory
cell traffic. In this study we examined the potential role of FDP in
neutrophil recruitment to the lung. Using a chemotaxis assay, we found that
FDP are potent chemotactic proteins when neutrophils are prestimulated with
lipopolysaccharide (LPS) or formylmethionylleucylphenylalanine (fMLP).
Although FDP are high molecular weight proteins, we found that these potent
chemoattractants induce polymorphonuclear leukocyte (PMN) migration across
epithelial monolayers. The magnitude of response is dependent upon the
monolayers' ability to form and maintain tight junctions. Human neutrophil
elastase (HNE), another fibrinolytic enzyme released from neutrophils,
digests fibrin into chemotactic peptides which are more potent on a weight
basis than plasmin-generated FDP. Furthermore, HNE secondarily digests
plasmin FDP, producing molecules which are more potent chemoattractants
than native plasmin FDP. These observations suggest a potential mechanism
whereby FDP may contribute to the neutrophil accumulation which
characterizes many inflammatory lung diseases.
This article has been cited by other articles:

|
 |

|
 |
 
M. Hoffman, A. Harger, A. Lenkowski, U. Hedner, H. R. Roberts, and D. M. Monroe
Cutaneous wound healing is impaired in hemophilia B
Blood,
November 1, 2006;
108(9):
3053 - 3060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Adair-Kirk, J. J. Atkinson, D. G. Kelley, R. H. Arch, J. H. Miner, and R. M. Senior
A Chemotactic Peptide from Laminin {alpha}5 Functions as a Regulator of Inflammatory Immune Responses via TNF{alpha}-mediated Signaling
J. Immunol.,
February 1, 2005;
174(3):
1621 - 1629.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Kerlin, B. C. Cooley, B. H. Isermann, I. Hernandez, R. Sood, M. Zogg, S. B. Hendrickson, M. W. Mosesson, S. Lord, and H. Weiler
Cause-effect relation between hyperfibrinogenemia and vascular disease
Blood,
March 1, 2004;
103(5):
1728 - 1734.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. L. Schagat, J. A. Wofford, K. E. Greene, and J. R. Wright
Surfactant protein A differentially regulates peripheral and inflammatory neutrophil chemotaxis
Am J Physiol Lung Cell Mol Physiol,
January 1, 2003;
284(1):
L140 - L147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-C. Murciano, D. Harshaw, D. G. Neschis, L. Koniaris, K. Bdeir, S. Medinilla, A. B. Fisher, M. A. Golden, D. B. Cines, M. T. Nakada, et al.
Platelets inhibit the lysis of pulmonary microemboli
Am J Physiol Lung Cell Mol Physiol,
March 1, 2002;
282(3):
L529 - L539.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. M. Swaisgood, E. L. French, C. Noga, R. H. Simon, and V. A. Ploplis
The Development of Bleomycin-Induced Pulmonary Fibrosis in Mice Deficient for Components of the Fibrinolytic System
Am. J. Pathol.,
July 1, 2000;
157(1):
177 - 187.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. KAWABATA, T. HAGIO, S. MATSUMOTO, S. NAKAO, S. ORITA, Y. AZE, and H. OHNO
Delayed Neutrophil Elastase Inhibition Prevents Subsequent Progression of Acute Lung Injury Induced by Endotoxin Inhalation in Hamsters
Am. J. Respir. Crit. Care Med.,
June 1, 2000;
161(6):
2013 - 2018.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
A. F. Shorr and O. W. Hnatiuk
Circulating D Dimer in Patients With Sarcoidosis
Chest,
April 1, 2000;
117(4):
1012 - 1016.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-F. Cordier
Rare diseases bullet 8: Organising pneumonia
Thorax,
April 1, 2000;
55(4):
318 - 328.
[Full Text]
|
 |
|

|
 |

|
 |
 
A. GÜNTHER, P. MOSAVI, S. HEINEMANN, C. RUPPERT, H. MUTH, P. MARKART, F. GRIMMINGER, D. WALMRATH, B. TEMMESFELD-WOLLBRÜCK, and W. SEEGER
Alveolar Fibrin Formation Caused by Enhanced Procoagulant and Depressed Fibrinolytic Capacities in Severe Pneumonia . Comparison with the Acute Respiratory Distress Syndrome
Am. J. Respir. Crit. Care Med.,
February 1, 2000;
161(2):
454 - 462.
[Abstract]
[Full Text]
|
 |
|

|
 |

|
 |
 
M. W. Peterson and J. Kirschbaum
Asbestos-induced lung epithelial permeability: potential role of nonoxidant pathways
Am J Physiol Lung Cell Mol Physiol,
August 1, 1998;
275(2):
L262 - L268.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. G. Sitrin, P. M. Pan, S. Srikanth, and R. F. Todd III
Fibrinogen Activates NF-{kappa}B Transcription Factors in Mononuclear Phagocytes
J. Immunol.,
August 1, 1998;
161(3):
1462 - 1470.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. KOBAYASHI, E. C. GABAZZA, O. TAGUCHI, H. WADA, H. TAKEYA, J. NISHIOKA, H. YASUI, T. KOBAYASHI, O. HATAJI, K. SUZUKI, et al.
Protein C Anticoagulant System in Patients with Interstitial Lung Disease
Am. J. Respir. Crit. Care Med.,
June 1, 1998;
157(6):
1850 - 1854.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Lardot, M. Delos, and D. Lison
Upregulation of urokinase in alveolar macrophages and lung tissue in response to silica particles
Am J Physiol Lung Cell Mol Physiol,
June 1, 1998;
274(6):
L1040 - L1048.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 1996 American Thoracic Society.
|
|
|